Clinical research of flixotide aerosol,montelukast in the treatment of bronchial asthma
XIE Hai-shuang
LIN Hao-hui
LIN Liang-kai
ZHOU Rong-cai
Abstract：Objective To investigate the clinical efficacy of the treatment with flixotide aerosol combination montelukast for Bronchial Asthma. Methods 60 patients with Bronchial Asthma were randomly divided into 2 groups, control group & treatment group each 30 cases. Control group used conventional basic treatment, like oxygen, anti-inflammatory, bronchial expansion, and the systemic glucocorticoid treatment, and treatment group was also in the conventional way, moreover, plus the treatment of flixotide aerosol and oral montelukast chewable tablets. 14 days for a course of treatment, after a course of treatment, the two groups were compared in the efficacy and lung function changes. Results The total effective rate in the treatment group was 90%, higher than that of the control group total effectiveness 66.7%, two groups of curative effect by Ridit analysis, the treatment group was significantly better than the control group (U=2.2733, p<0.05), treatment during the two groups had no obvious adverse reaction. Conclusion It is much better to use the conventional treatment then plus the treatment of flixotide aerosol and montelukast for Bronchial Asthma, thus it is worth promoting in clinical.
Keywords：flixotide aerosolMontelukastLeukotriene antibodyBronchial Asthma
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 34-36 )